Nicotine dependence (trait) and acute nicotinic stimulation (state) modulate attention but not inhibitory control: converging fMRI evidence from Go-Nogo and Flanker tasks.


Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907

Informations de publication

Date de publication:
04 2020
Historique:
received: 21 08 2019
accepted: 17 01 2020
revised: 29 12 2019
pubmed: 30 1 2020
medline: 31 3 2021
entrez: 30 1 2020
Statut: ppublish

Résumé

Cognitive deficits during nicotine withdrawal may contribute to smoking relapse. However, interacting effects of chronic nicotine dependence and acute nicotine withdrawal on cognitive control are poorly understood. Here we examine the effects of nicotine dependence (trait; smokers (n = 24) vs. non-smoking controls; n = 20) and acute nicotinic stimulation (state; administration of nicotine and varenicline, two FDA-approved smoking cessation aids, during abstinence), on two well-established tests of inhibitory control, the Go-Nogo task and the Flanker task, during fMRI scanning. We compared performance and neural responses between these four pharmacological manipulations in a double-blind, placebo-controlled crossover design. As expected, performance in both tasks was modulated by nicotine dependence, abstinence, and pharmacological manipulation. However, effects were driven entirely by conditions that required less inhibitory control. When demand for inhibitory control was high, abstinent smokers showed no deficits. By contrast, acutely abstinent smokers showed performance deficits in easier conditions and missed more trials. Go-Nogo fMRI results showed decreased inhibition-related neural activity in right anterior insula and right putamen in smokers and decreased dorsal anterior cingulate cortex activity on nicotine across groups. No effects were found on inhibition-related activity during the Flanker task or on error-related activity in either task. Given robust nicotinic effects on physiology and behavioral deficits in attention, we are confident that pharmacological manipulations were effective. Thus findings fit a recent proposal that abstinent smokers show decreased ability to divert cognitive resources at low or intermediate cognitive demand, while performance at high cognitive demand remains relatively unaffected, suggesting a primary attentional deficit during acute abstinence.

Identifiants

pubmed: 31995811
doi: 10.1038/s41386-020-0623-1
pii: 10.1038/s41386-020-0623-1
pmc: PMC7075893
doi:

Substances chimiques

Nicotinic Agonists 0
Nicotine 6M3C89ZY6R
Varenicline W6HS99O8ZO

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

857-865

Subventions

Organisme : NIDA NIH HHS
ID : K01 DA037819
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA041353
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD012393
Pays : United States

Références

Center for Disease Control. Quitting smoking among adults–United States, 2001–2010. MMWR Weekly. 2014;60:1513–19.
Powell J, Dawkins L, West R, Powell J, Pickering A. Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors. Psychopharmacology (Berl). 2010;212:537–49. https://doi.org/10.1007/s00213-010-1975-8
doi: 10.1007/s00213-010-1975-8
Sutherland MT, Carroll AJ, Salmeron BJ, Ross TJ, Hong LE, Stein Ea. Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers. Biol Psychiatry. 2013;74:1–9. https://doi.org/10.1016/j.biopsych.2013.01.035
doi: 10.1016/j.biopsych.2013.01.035
Fedota JR, Sutherland MT, Salmeron BJ, Ross TJ, Hong LE, Stein EA. Reward anticipation is differentially modulated by varenicline and nicotine in smokers. Neuropsychopharmacology. 2015;40:2038–46. https://doi.org/10.1038/npp.2015.54
doi: 10.1038/npp.2015.54 pubmed: 25742873 pmcid: 4839527
Rose EJ, et al. Acute nicotine differentially impacts anticipatory valence- and magnitude-related striatal activity. Biol Psychiatry. 2013;73:280–8. https://doi.org/10.1016/j.biopsych.2012.06.034
doi: 10.1016/j.biopsych.2012.06.034 pubmed: 22939991
Rose EJ, et al. Chronic exposure to nicotine is associated with reduced reward-related activity in the striatum but not the midbrain. Biol Psychiatry. 2012;71:206–13. https://doi.org/10.1016/j.biopsych.2011.09.013
doi: 10.1016/j.biopsych.2011.09.013 pubmed: 22032832
Ashare RL, Falcone M, Lerman C. Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology. 2014;76:581–91. https://doi.org/10.1016/j.neuropharm.2013.04.034
doi: 10.1016/j.neuropharm.2013.04.034
Ernst M, et al. Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci USA. 2001;98:4728–33.
doi: 10.1073/pnas.061369098
Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159:1642–52.
doi: 10.1176/appi.ajp.159.10.1642
Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med. 2016;374:363–71. https://doi.org/10.1056/NEJMra1511480
doi: 10.1056/NEJMra1511480 pubmed: 26816013 pmcid: 6135257
Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362:2295–303. https://doi.org/10.1056/NEJMra0809890
doi: 10.1056/NEJMra0809890 pubmed: 20554984 pmcid: 2928221
Lesage E, Stein EA. Networks associated with reward. In: Pfaff DW, ND Volkow ND, editors. Neuroscience in the 21st century. New York, NY: Springer New York; 2016. pp. 1–27.
Hahn B. Nicotinic receptors and attention. In: Balfour DJK, Munafò MR, editors. The neurobiology and genetics of nicotine and tobacco. Cham: Springer International Publishing; 2015. pp. 103–35.
Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10:561–72. https://doi.org/10.1038/nrn2515
doi: 10.1038/nrn2515 pubmed: 19571793
Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35:217–38.
doi: 10.1038/npp.2009.110
Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci. 2007;28:316–25. https://doi.org/10.1016/j.tips.2007.05.003
doi: 10.1016/j.tips.2007.05.003 pubmed: 17573127
Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal. J Clin Psychopharmacol. 2008;28:667–74. https://doi.org/10.1097/JCP.0b013e31818c9bb8
doi: 10.1097/JCP.0b013e31818c9bb8 pubmed: 19011436
Cahill K, Lindson‐Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016. https://doi.org/10.1002/14651858.CD006103.pub7
Hartmann‐Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD000146.pub5
Eriksen BA, Eriksen CW. Effects of noise letters upon the identification of a target letter in a nonsearch task. Percept Psychophys. 1974;16:143–9. https://doi.org/10.3758/BF03203267
doi: 10.3758/BF03203267
Luijten M, Machielsen M, Veltman D, Hester R, de Haan L, Franken I. Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people. J Psychiatry Neurosci. 2014;39:149–69. https://doi.org/10.1503/jpn.130052
doi: 10.1503/jpn.130052 pubmed: 24359877 pmcid: 3997601
Smith JL, Mattick RP, Jamadar SD, Iredale JM. Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis. Drug Alcohol Depend. 2014;145:1–33. https://doi.org/10.1016/j.drugalcdep.2014.08.009
doi: 10.1016/j.drugalcdep.2014.08.009 pubmed: 25195081
Cieslik EC, Mueller VI, Eickhoff CR, Langner R, Eickhoff SB. Three key regions for supervisory attentional control: Evidence from neuroimaging meta-analyses. Neurosci Biobehav Rev. 2015;48:22–34. https://doi.org/10.1016/j.neubiorev.2014.11.003
doi: 10.1016/j.neubiorev.2014.11.003 pubmed: 25446951
Simmonds DJ, Pekar JJ, Mostofsky SH. Meta-analysis of Go/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent. Neuropsychologia. 2008;46:224–32. https://doi.org/10.1016/j.neuropsychologia.2007.07.015
doi: 10.1016/j.neuropsychologia.2007.07.015 pubmed: 17850833
Zhang R, Geng X, Lee TMC. Large-scale functional neural network correlates of response inhibition: an fMRI meta-analysis. Brain Struct Funct. 2017;222:3973–90. https://doi.org/10.1007/s00429-017-1443-x
doi: 10.1007/s00429-017-1443-x pubmed: 28551777 pmcid: 5686258
Luijten M, et al. The role of dopamine in inhibitory control in smokers and non-smokers: a pharmacological fMRI study. Eur Neuropsychopharmacol. 2013;23:1247–56. https://doi.org/10.1016/j.euroneuro.2012.10.017
doi: 10.1016/j.euroneuro.2012.10.017 pubmed: 23194834
Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3:760–73. https://doi.org/10.1016/S2215-0366(16)00104-8
doi: 10.1016/S2215-0366(16)00104-8 pubmed: 27475769 pmcid: 6135092
Kaufman JN, Ross TJ, Stein EA, Garavan H. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci. 2003;23:7839–43.
doi: 10.1523/JNEUROSCI.23-21-07839.2003
Luijten M, Littel M, Franken IHA. Deficits in inhibitory control in smokers during a Go/NoGo task: an investigation using event-related brain potentials. PLoS ONE. 2011;6:e18898. https://doi.org/10.1371/journal.pone.0018898
doi: 10.1371/journal.pone.0018898 pubmed: 21526125 pmcid: 3081309
Nestor L, McCabe E, Jones J, Clancy L, Garavan H. Differences in ‘bottom-up’ and ‘top-down’ neural activity in current and former cigarette smokers: evidence for neural substrates which may promote nicotine abstinence through increased cognitive control. Neuroimage. 2011;56:2258–75. https://doi.org/10.1016/j.neuroimage.2011.03.054
doi: 10.1016/j.neuroimage.2011.03.054 pubmed: 21440645
Buzzell GA, Fedota JR, Roberts DM, McDonald CG. The N2 ERP component as an index of impaired cognitive control in smokers. Neurosci Lett. 2014;563:61–5. https://doi.org/10.1016/j.neulet.2014.01.030
doi: 10.1016/j.neulet.2014.01.030 pubmed: 24486891
Carim-Todd L, Mitchell SH, Oken BS. Impulsivity and stress response in nondependent smokers (tobacco chippers) in comparison to heavy smokers and nonsmokers. Nicotine Tob Res. 2016;18:547–56. https://doi.org/10.1093/ntr/ntv210
doi: 10.1093/ntr/ntv210 pubmed: 26391579
Barr RS, et al. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology. 2008;33:480–90. https://doi.org/10.1038/sj.npp.1301423
doi: 10.1038/sj.npp.1301423 pubmed: 17443126
Valentine G, Sofuoglu M. Cognitive effects of nicotine: recent progress. Curr Neuropharmacol. 2018;16:403–14. https://doi.org/10.2174/1570159X15666171103152136
doi: 10.2174/1570159X15666171103152136 pubmed: 29110618 pmcid: 6018192
Foulds J, Stapleton J, Swettenham J, Bell N, McSorley K, Russell MAH. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl). 1996;127:31–8. https://doi.org/10.1007/BF02805972
doi: 10.1007/BF02805972
Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl). 2010;210:453–69. https://doi.org/10.1007/s00213-010-1848-1
doi: 10.1007/s00213-010-1848-1
Ettinger U, et al. Effects of nicotine on response inhibition and interference control. Psychopharmacology (Berl). 2017;234:1093–111. https://doi.org/10.1007/s00213-017-4542-8
doi: 10.1007/s00213-017-4542-8
Zelle SL, Gates KM, Fiez JA, Sayette MA, Wilson SJ. The first day is always the hardest: functional connectivity during cue exposure and the ability to resist smoking in the initial hours of a quit attempt. NeuroImage. 2017;151:24–32. https://doi.org/10.1016/j.neuroimage.2016.03.015
doi: 10.1016/j.neuroimage.2016.03.015 pubmed: 26975550
Lesage E, Aronson SE, Sutherland MT, Ross TJ, Salmeron BJ, Stein EA. Neural signatures of cognitive flexibility and reward sensitivity following nicotinic receptor stimulation in dependent smokers: a randomized trial. JAMA Psychiatry. 2017;74:632–40. https://doi.org/10.1001/jamapsychiatry.2017.0400
doi: 10.1001/jamapsychiatry.2017.0400 pubmed: 28403383 pmcid: 5539833
Carroll AJ, Sutherland MT, Salmeron BJ, Ross TJ, Stein EA. Greater externalizing personality traits predict less error-related insula and anterior cingulate cortex activity in acutely abstinent cigarette smokers. Addict Biol. 2015;20:377–89. https://doi.org/10.1111/adb.12118
doi: 10.1111/adb.12118 pubmed: 24354662
Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res Int J. 1996;29:162–73.
doi: 10.1006/cbmr.1996.0014
Afyouni S, Nichols TE. Insight and inference for DVARS. Neuroimage. 172:291–312. https://doi.org/10.1016/j.neuroimage.2017.12.098
Seeley WW, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007;27:2349–56. https://doi.org/10.1523/JNEUROSCI.5587-06.2007
doi: 10.1523/JNEUROSCI.5587-06.2007 pubmed: 17329432 pmcid: 2680293
Xu M, Xu G, Yang Y. Neural systems underlying emotional and non-emotional interference processing: an ALE meta-analysis of functional neuroimaging studies. Front Behav Neurosci. 2016. https://doi.org/10.3389/fnbeh.2016.00220
Hahn B, Ross TJ, Wolkenberg FA, Shakleya DM, Huestis MA, Stein EA. Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study. Cereb Cortex. 2009;19:1990–2000. https://doi.org/10.1093/cercor/bhn226
doi: 10.1093/cercor/bhn226 pubmed: 19073624
Fedota JR, et al. Nicotine abstinence influences the calculation of salience in discrete insular circuits. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:150–9. https://doi.org/10.1016/j.bpsc.2017.09.010
doi: 10.1016/j.bpsc.2017.09.010 pubmed: 29529410
Grundey J, Amu R, Ambrus GG, Batsikadze G, Paulus W, Nitsche MA. “Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine,”. Psychopharmacology (Berl). 2015;232:2491–501. https://doi.org/10.1007/s00213-015-3880-7
doi: 10.1007/s00213-015-3880-7
Lawrence NS, Ross TJ, Stein EA. Cognitive mechanisms of nicotine on visual attention. Neuron. 2002;36:539–48. https://doi.org/10.1016/S0896-6273(02)01004-8
doi: 10.1016/S0896-6273(02)01004-8 pubmed: 12408855
Sutherland MT, Carroll AJ, Salmeron BJ, Ross TJ, Hong LE, Stein EA. Individual differences in amygdala reactivity following nicotinic receptor stimulation in abstinent smokers. Neuroimage. 2013;66:585–93. https://doi.org/10.1016/j.neuroimage.2012.10.043
doi: 10.1016/j.neuroimage.2012.10.043 pubmed: 23110878
Kozink RV, Kollins SH, McClernon FJ. Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control. Neuropsychopharmacology. 2010;35:2600–6. https://doi.org/10.1038/npp.2010.154
doi: 10.1038/npp.2010.154 pubmed: 20861830 pmcid: 2978758
Weywadt CR, Kiehl KA, Claus ED. Neural correlates of response inhibition in current and former smokers. Behav Brain Res. 2017;319:207–18. https://doi.org/10.1016/j.bbr.2016.11.030
doi: 10.1016/j.bbr.2016.11.030 pubmed: 27867102
Rass O, Fridberg DJ, O’Donnell BF. Neural correlates of performance monitoring in daily and intermittent smokers. Clin Neurophysiol. 2014;125:1417–26. https://doi.org/10.1016/j.clinph.2013.12.001
doi: 10.1016/j.clinph.2013.12.001 pubmed: 24380760
Fedota JR, Matous AL, Salmeron BJ, Gu H, Ross TJ, Stein EA. Insula demonstrates a non-linear response to varying demand for cognitive control and weaker resting connectivity with the executive control network in smokers. Neuropsychopharmacology. 2016;41:2557–65. https://doi.org/10.1038/npp.2016.62
doi: 10.1038/npp.2016.62 pubmed: 27112116 pmcid: 4987854
Evans DE, Craig C, Oliver JA, Drobes DJ. The smoking N-back: a measure of biased cue processing at varying levels of cognitive load. Nicotine Tob Res. 2011;13:88–93. https://doi.org/10.1093/ntr/ntq214
doi: 10.1093/ntr/ntq214 pubmed: 21127029
Dosenbach NUF, et al. Distinct brain networks for adaptive and stable task control in humans. Proc Natl Acad Sci USA. 2007;104:11073–8. https://doi.org/10.1073/pnas.0704320104
doi: 10.1073/pnas.0704320104 pubmed: 17576922
Eckert MA, et al. At the heart of the ventral attention system: the right anterior insula. Hum Brain Mapp. 2009;30:2530–41. https://doi.org/10.1002/hbm.20688
doi: 10.1002/hbm.20688 pubmed: 19072895 pmcid: 2712290
Yuan K, et al. Striato-cortical tracts predict 12-h abstinence-induced lapse in smokers. Neuropsychopharmacology. 2018;43:2452–8. https://doi.org/10.1038/s41386-018-0182-x
doi: 10.1038/s41386-018-0182-x pubmed: 30131564 pmcid: 6180048
Bi Y, et al. Altered resting state functional connectivity of anterior insula in young smokers. Brain Imaging Behav. 2017;11:155–65. https://doi.org/10.1007/s11682-016-9511-z
doi: 10.1007/s11682-016-9511-z pubmed: 26843002
Azizian A, Nestor LJ, Payer D, Monterosso JR, Brody AL, London ED. Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a stroop task. Neuropsychopharmacology. 2010;35:775–82. https://doi.org/10.1038/npp.2009.186
doi: 10.1038/npp.2009.186 pubmed: 19907418
Nestor L, McCabe E, Jones J, Clancy L, Garavan H. Differences in ‘bottom-up’ and ‘top-down’ neural activity in current and former cigarette smokers: evidence for neural substrates which may promote nicotine abstinence through increased cognitive control. NeuroImage. 2011;56:2258–75. https://doi.org/10.1016/j.neuroimage.2011.03.054
doi: 10.1016/j.neuroimage.2011.03.054 pubmed: 21440645
Hester R, Fassbender C, Garavan H. Individual differences in error processing: a review and reanalysis of three event-related fMRI studies using the GO/NOGO task. Cereb Cortex. 2004;14:986–94. https://doi.org/10.1093/cercor/bhh059
doi: 10.1093/cercor/bhh059 pubmed: 15115734

Auteurs

E Lesage (E)

Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Department of Experimental Psychology, Gent University, Ghent, Belgium.

M T Sutherland (MT)

Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Department of Psychology, Florida International University, Miami, FL, USA.

T J Ross (TJ)

Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.

B J Salmeron (BJ)

Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.

E A Stein (EA)

Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA. Estein@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH